PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review

201396 citationsReview

Authors

Andrew T. Kunzmann · Institute of Public Health

Liam Murray · Institute of Public Health

Chris R. Cardwell · Institute of Public Health

Charlene M. McShane · Institute of Public Health

Úna C. McMenamin · Institute of Public Health

Marie M. Cantwell · Institute of Public Health

Abstract

There is insufficient evidence to recommend PTGS2 expression as a prognostic marker in patients with colorectal cancer. Furthermore, studies providing adjusted results are required.

Topics & Keywords

Inflammatory mediators and NSAID effects Cancer, Lipids, and Metabolism Estrogen and related hormone effects

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Cancer Epidemiology Biomarkers & Prevention

Volume 22, Issue 9, pp. 1490-1497

DOI: 10.1158/1055-9965.epi-13-0263

Field-Weighted Citation Impact: 2.32